课题基金 / 基金详情

Asthma and Allergic Diseases Cooperative Research Center

Asthma and Allergic Diseases Cooperative Research Center
哮喘与过敏性疾病合作研究中心
批准号:
7920914
负责人:
Yong-Jun Liu
金额:
$113.98万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2011-06-30

项目摘要

项目成果

Yong-Jun Liu的其他基金

相似基金

相关文献

中文摘要
翻译
这是一个应用程序的得克萨斯州医学中心NIH/NIAID哮喘和过敏性疾病合作研究中心,联合得克萨斯大学医学博士。安德森癌症中心和贝勒医学院研究人胸腺基质细胞生成素(TSLP)在Th 2免疫应答的发展和维持中的作用,Th 2免疫应答主导过敏表型。拟议的研究将测试总体假设,即TSLP是发展和维持特应性和哮喘的主开关。TSLP是在Th 2细胞因子基因的人染色体5 q22簇上编码的造血细胞因子,并且在人中主要由上皮细胞和活化的肥大细胞产生,并且在特应性皮炎和过敏性哮喘的情况下表达。过敏性疾病的基因工程小鼠模型也支持TSLP在特应性的病理生物学中的核心作用。该提案整合了四个研究项目,两个研究核心和一个以TSLP为重点的行政核心。项目一研究人呼吸道上皮细胞和肥大细胞诱导TSLP表达的机制。项目2将确定TSLP激活髓样树突状细胞的机制。项目3将阐明TSLP激活的髓样树突状细胞增殖Th 2效应细胞和记忆细胞的机制。项目4将重点关注炎症性T辅助细胞(Thi)在TSLP产生上调中的作用。这些项目将由行政核心,分析研究核心和临床研究核心支持。拟议的研究将为过敏性疾病和哮喘的机制提供新的见解,并可能确定新的治疗干预靶点。
英文摘要
This is an application for a Texas Medical Center NIH/NIAID Asthma and Allergic Diseases Cooperative Research Center that unites the University of Texas M.D. Anderson Cancer Center and Baylor College of Medicine to investigate the role of human Thymic Stromal Lymphopoietin (TSLP) in the development and maintenance of the Th2 immune response that dominates the allergic phenotype. The proposed studies will test the overall hypothesis that TSLP is a master switch for developing and maintaining atopy and asthma. TSLP is a hematopoietic cytokine encoded on the human chromosome 5q22 cluster of Th2 cytokine genes, and in humans is produced predominately by epithelial cells and activated mast cells, and is expressed in the context of atopic dermatitis and allergic asthma. Genetically engineered murine models of allergic disease also support a central role for TSLP in the pathobiology of atopy. This proposal integrates four research projects, two research cores and an administrative core focused on TSLP. Project 1 will investigate the mechanisms for induction of TSLP expression by human respiratory epithelial cells and mast cells. Project 2 will determine the mechanisms by which TSLP activates myeloid dendritic cells. Project 3 will elucidate mechanisms by which TSLP activated myeloid dendritic cells propagate Th2 effecter and memory cells. Project 4 will focus on the role of inflammatory T helper cells (Thi) in the upregulation of TSLP production. These projects will be supported by an Administrative Core, an Analytical Research Core, and a Clinical Research Core. The proposed studies should provide new insight into the mechanisms of allergic disease and asthma, and potentially identify new targets for therapeutic intervention.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
TSLP enhances the function of helper type 2 cells.
TSLP增强了辅助2型细胞的功能。
DOI: 10.1002/eji.201041195
发表时间: 2011-07
期刊: EUROPEAN JOURNAL OF IMMUNOLOGY
影响因子: 5.4
作者: [Kitajima, Masayuki, Lee, Hai-Chon, Nakayama, Toshinori, Ziegler, Steven F.]
通讯作者: Ziegler, Steven F.
DOI: 10.1084/jem.20070406
发表时间: 2007-08-06
期刊: The Journal of experimental medicine
影响因子: --
作者: [Wang YH, Angkasekwinai P, Lu N, Voo KS, Arima K, Hanabuchi S, Hippe A, Corrigan CJ, Dong C, Homey B, Yao Z, Ying S, Huston DP, Liu YJ]
通讯作者: Liu YJ
DOI: 10.3346/jkms.2010.25.6.829
发表时间: 2010-06
期刊: Journal of Korean medical science
影响因子: 4.5
作者: [Yu HS, Angkasekwinai P, Chang SH, Chung Y, Dong C]
通讯作者: Dong C
DOI: 10.4049/jimmunol.1302175
发表时间: 2013-11-15
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Kitajima M, Ziegler SF]
通讯作者: Ziegler SF
共 6 条
    Understanding the early and late endosomal TLR9-mediated responses to viral DNA.
    • 批准号:
      8637914
    • 项目类别:
    • 资助金额:
      $39.2万
    • 财政年份:
      2012
    • 负责人:
      Yong-Jun Liu
    • 依托单位:
    Targeting Plasmacytoid Dendritic Cells to Treat Human Myeloma
    • 批准号:
      8721606
    • 项目类别:
    • 资助金额:
      $26.85万
    • 财政年份:
      2012
    • 负责人:
      Yong-Jun Liu
    • 依托单位:
    Understanding the early and late endosomal TLR9-mediated responses to viral DNA.
    • 批准号:
      8451259
    • 项目类别:
    • 资助金额:
      $36.85万
    • 财政年份:
      2012
    • 负责人:
      Yong-Jun Liu
    • 依托单位:
    Targeting Plasmacytoid Dendritic Cells to Treat Human Myeloma
    海外基金